Immunocore Holdings (IMCR) Other financing activities (2024)
Immunocore Holdings' (IMCR) quarterly Other financing activities came in at $1.1 million in Q2 2024, down 90.88% quarter-over-quarter from $12.2 million in Q1 2024.
Immunocore Holdings (IMCR) Other financing activities (2024) Analysis & Trends
Immunocore Holdings has disclosed Other financing activities across 1 years of filings, most recently posting $1.1 million for Q2 2024.
- Other financing activities for Q2 2024 came in at $1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $1.1 million (down 90.88% YoY), and the FY2024 annual result was $13.4 million, changed N/A from the prior year.
- Other financing activities came in at $1.1 million for Q2 2024 at Immunocore Holdings, down from $12.2 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $12.2 million in Q1 2024 to a low of $1.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 12.24 Mn |
| Mar 31, 2024 | 12.24 Mn |